Skip to main content
TipRanks
Go Ultimate75% OFF

Cullinan Management (CGEM) Drug Pipeline

393 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Velinotamig Specified Dose On Specified Days.Warm Autoimmune Hemolytic Anemia (Waiha), Immune Thrombocytopenia (Itp)phase1AndPhase2Not Yet RecruitingA Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHAJul 28, 2026
Venetoclax, Azacitidine, Cln-049Aml (Acute Myeloid Leukemia)Phase INot Yet RecruitingA Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML PatientsJul 15, 2026―
Cln-978Rheumatoid Arthritis (RaPhase IRecruitingA Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid ArthritisMay 20, 2025
Cln-978Sle (Systemic Lupus), SlePhase IRecruitingA Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus ErythematosusSep 20, 2024
Pembrolizumab, Cln-617, KeytrudaAdvanced Solid TumorPhase ITerminatedCLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid TumorsAug 31, 2023―
Cln-978Nhl, Nhl, Relapsed, AdultPhase ITerminatedA Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)May 05, 2023―
Cln-049Myelodysplastic Syndrome (Mds), Relapsed/Refractory Acute Myeloid Leukemia (Aml), Tp53-Mutated Mds And Amlphase1AndPhase2RecruitingCLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Oct 26, 2021―
Cln-081Non Small Cell Lung Cancer, Egfr Exon 20 Mutationphase1AndPhase2Active Not RecruitingA Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerJul 23, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cullinan Therapeutics Inc (CGEM) have in its pipeline
Cullinan Management CGEM is currently developing the following drugs: Velinotamig Specified Dose On Specified Days., Venetoclax, Azacitidine, Cln-049, Cln-978, Pembrolizumab, Cln-617, Keytruda, Cln-049, Cln-081. These drug candidates are in various stages of clinical development as the company works toward FDA approval.